OptimizeRx has launched its patent-pending Natural Language Audience Builder, an AI-powered tool designed to be embedded within demand-side platforms and agency media planning platforms. The tool combines real-world evidence with proprietary data from OptimizeRx’s EHR network, enabling life sciences companies and agency marketers to create and manage custom healthcare provider audiences without code or analyst support. Marketers can view, rank, and filter matching HCP profile details including specialty, patient volumes, and prescribing behavior, and understand NPI-level reach across programmatic, social, EHR, and field force channels. The launch builds on OptimizeRx’s prior opening of programmatic access to its authenticated EHR inventory and expands its role as an infrastructure partner for life sciences manufacturers, agencies, and DSPs. NLAB will be available for platform integration from August 2026 and can be bundled with the integration of OptimizeRx’s authenticated point of care inventory.
OPTIMIZERx CorpLaunches patent-pending AI-powered Natural Language Audience Builder, a new product for life sciences marketing.